Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.
Roche posts higher sales on growth scross pharma, diagnostics units
Discover more from UM LEGACY PRESS LTD
Subscribe to get the latest posts sent to your email.